Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: T-Lo Greens who wrote (87)	7/14/1999 3:09:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2557

Tony: meningitis, which is the Phase 3 you're referring to, is NOT the common cold. Gee, no kidding!? The phase II trial for severe "cold" will be published in a peer-reviewed forum. The results are strong, and you can bet on it. Review the phase III results for meningitis and pending litigation re. FDA off-label promotion, and you'll get the point if not see light. The sales estimate that I gave for 2002 was for meningitis. It's always humorous when the daytraders hit biotech..... "it's $40, and it's overvalued, short!!" You haven't a clue of relative valuations or what it costs for a pharma to put together an anti-viral franchise. I don't give a damn what it closes at today, 30 or 10. I sold my trading position (established 6/17 at 7 3/16) this morning and kept my long-term hold portion. So, good luck! Won't mind you being successful in the least, even in your ignorance of what you're trading. Rick